Country | Source | Sample size | Date | Risk group | Outcome | Relative risk (95%CI) |
---|---|---|---|---|---|---|
Spain | ISCIII | 250287 | 21.05.2020 | Cardiovascular disease | Death | 4.6 (4.6–4.7) |
Respiratory disease | 3.0 (3.0–3.0) | |||||
Diabetes | 3.4 (3.4–3.5) | |||||
At least one comorbidity | 6.6 (6.5–6.6) | |||||
France | Santé publique France | 3784 | 18.05.2020 | Morbid obesity (BMI>40) | Death | 0.9 (0.6–1.2) |
Diabetes | 1.3 (1.2–1.5) | |||||
Cardiac disease | 1.9 (1.7–2.0) | |||||
Pulmonary disease | 1.5 (1.3–1.7) | |||||
Immunodeficiency | 1.6 (1.3–1.8) | |||||
Renal disease | 1.6 (1.4–1.9) | |||||
Neuromuscular disorder | 2.1 (1.8–2.4) |